Objective: Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor positive operable breast cancer in some older women. However the decision to offer PET involves complex trade-offs and is influenced by both patient choice and healthcare professional (HCP) preference. This study aimed to compare the views of patients and HCPs about this decision and explore decision-making (DM) preferences and whether these are taken into account during consultations. Methods: This multicentre, UK, mixed methods study had three components: (a) questionnaires to older women undergoing counseling about breast cancer treatment options which assessed their DM preferences and realities; (b) qualitative interviews with older women with...
Primary endocrine therapy (PET) as an alternative to surgery is widely used in the UK for the treatm...
Background: Primary endocrine therapy (PET) is a recognised alternative to surgery followed by endoc...
BACKGROUND: Decisions about adjuvant chemotherapy in older women with early stage breast cancer (EBC...
Objective Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor posit...
Objective: Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor pos...
Purpose: Primary endocrine therapy (PET) is the treatment of primary, operable breast cancer with d...
INTRODUCTION: Primary endocrine therapy (PET) is used variably in the UK as an alternative to surger...
Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer in olde...
Abstract Introduction Primary endocrine therapy (PET) is an alternative treatment to surgery for oes...
Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer in old...
Introduction Primary endocrine therapy (PET) is used variably in the UK as an alternative to surg...
Objectives: To establish older women's (≥75 years) information preferences regarding two breast canc...
Objectives: To establish older women's (≥75 years) information preferences regarding two breast canc...
Abstract: Background: Most studies on cancer patient preferences and information needs have not focu...
Primary endocrine therapy (PET) as an alternative to surgery is widely used in the UK for the treatm...
Background: Primary endocrine therapy (PET) is a recognised alternative to surgery followed by endoc...
BACKGROUND: Decisions about adjuvant chemotherapy in older women with early stage breast cancer (EBC...
Objective Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor posit...
Objective: Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor pos...
Purpose: Primary endocrine therapy (PET) is the treatment of primary, operable breast cancer with d...
INTRODUCTION: Primary endocrine therapy (PET) is used variably in the UK as an alternative to surger...
Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer in olde...
Abstract Introduction Primary endocrine therapy (PET) is an alternative treatment to surgery for oes...
Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer in old...
Introduction Primary endocrine therapy (PET) is used variably in the UK as an alternative to surg...
Objectives: To establish older women's (≥75 years) information preferences regarding two breast canc...
Objectives: To establish older women's (≥75 years) information preferences regarding two breast canc...
Abstract: Background: Most studies on cancer patient preferences and information needs have not focu...
Primary endocrine therapy (PET) as an alternative to surgery is widely used in the UK for the treatm...
Background: Primary endocrine therapy (PET) is a recognised alternative to surgery followed by endoc...
BACKGROUND: Decisions about adjuvant chemotherapy in older women with early stage breast cancer (EBC...